(Q34108215)

31 July 2017

title

Current issues in the economics of depression management (English)

1 reference

31 July 2017

Thompson D

1

1 reference

31 July 2017

Richardson E

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Current Psychiatry Reports

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

125-134

1 reference

Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-999-0021-1

Effect of primary care treatment of depression on service use by patients with high medical expenditures

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-999-0021-1

Depression and somatization: a review. Part I.

21 January 2018

1 reference

12 December 2020

Health economic evaluations of antidepressants: a review

1 reference

12 December 2020

Pharmacotherapy of depressive disorders. A consensus statement. WHO Mental Health Collaborating Centres

1 reference

12 December 2020

SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study

1 reference

12 December 2020

SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis

1 reference

12 December 2020

The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

1 reference

12 December 2020

The role of SSRI antidepressants for treating depressed patients in the California Medicaid (Medi-Cal) program

1 reference

12 December 2020

What does treatment of depression really cost?

1 reference

12 December 2020

Workplace performance effects from chronic depression and its treatment

1 reference

12 December 2020

Fluoxetine. A pharmacoeconomic review of its use in depression

1 reference

12 December 2020

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.

1 reference

12 December 2020

Antidepressant selection and use and healthcare expenditures. An empirical approach

1 reference

12 December 2020

Adequacy and duration of antidepressant treatment in primary care

1 reference

12 December 2020

Absenteeism among employees treated for depression.

1 reference

12 December 2020

Practice guideline for major depressive disorder in adults. American Psychiatric Association

1 reference

12 December 2020

A critical review of selected pharmacoeconomic analyses of antidepressant therapy

1 reference

12 December 2020

The added costs of depression to medical care

1 reference

12 December 2020

Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group

1 reference

12 December 2020

Depression, use of medical services and cost-offset effects

1 reference

12 December 2020

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

1 reference

12 December 2020

The impact of psychiatric disorders on work loss days.

1 reference

12 December 2020

Predictors of a medical-offset effect among patients receiving antidepressant therapy

1 reference

12 December 2020

Pharmacoeconomic issues in the treatment of depression

1 reference

12 December 2020

Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study.

1 reference

12 December 2020

The economic burden of depression in 1990.

1 reference

12 December 2020

10.1007/S11920-999-0021-1

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1027096967

0 references

1 reference